Overview Fundamentals API Earnings EOD API Sample Code Pricing

XERIS BIOPH.HOL. DL-0001 (2B30 F) stock market data APIs

€2.898 0(0%) as of October 29, 2024
Price chart is built with Anychart

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase I clinical trial for the treatment of hypothyroidism; and non-aqueous XeriSol and XeriJect technologies for various therapies. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.

XERIS BIOPH.HOL. DL-0001 Financial Data Overview

2.898
2.898
-
2.898
2.898
1.36-2.96
432 M
149 M
181 M
1.31
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '2B30',
Type: 'Common Stock',
Name: 'XERIS BIOPH.HOL. DL-0001',
Exchange: 'F',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Germany',
CountryISO: 'DE',
OpenFigi: NULL,
ISIN: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
CUSIP: NULL,
}

XERIS BIOPH.HOL. DL-0001 Fundamental Data is available in our Financial Data APIs

  • Net Revenue 181 M
  • EBITDA -24 999 000
  • Earnings Per Share -0.39
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get XERIS BIOPH.HOL. DL-0001 Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get XERIS BIOPH.HOL. DL-0001 End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com